Axel Schambach undertakes interdisciplinary study in the fields of Genetics and Enhancer through his research. In his works, Axel Schambach undertakes multidisciplinary study on Molecular biology and Vector (molecular biology). Axel Schambach undertakes multidisciplinary investigations into Vector (molecular biology) and Recombinant DNA in his work. By researching both Recombinant DNA and Transgene, he produces research that crosses academic boundaries. In his papers, he integrates diverse fields, such as Transgene and Viral vector. He combines Viral vector and Transfection in his studies. He undertakes interdisciplinary study in the fields of Transfection and Molecular biology through his research. His work blends Gene and Promoter studies together. In his papers, he integrates diverse fields, such as Promoter and Gene.
His Immunology study in the realm of Immune system connects with subjects such as Cancer research. In the field of Immunology he connects related research areas like Immune system and Antibody. He combines Cancer research and Genetics in his research. Many of his studies on Genetics involve topics that are commonly interrelated, such as In vivo. He is conducting research in Promoter and Long terminal repeat as part of his Gene expression study. He merges many fields, such as Promoter and Gene expression, in his writings. Axel Schambach integrates many fields, such as Gene and Cell culture, in his works. He conducts interdisciplinary study in the fields of Recombinant DNA and Transgene through his research. Axel Schambach combines Transgene and Recombinant DNA in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Skin tissue generation by laser cell printing.
Lothar Koch;Andrea Deiwick;Sabrina Schlie;Stefanie Michael.
Biotechnology and Bioengineering (2012)
Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity
Christian Jörg Braun;Kaan Boztug;Anna Paruzynski;Maximilian Witzel.
Science Translational Medicine (2014)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich;Susana Navarro;Daniela Zychlinski;Tobias Maetzig.
Molecular Therapy (2009)
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant.
The New England Journal of Medicine (2014)
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Ute Modlich;Jens Bohne;Manfred Schmidt;Christof von Kalle.
A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.
Jianwei Wang;Qian Sun;Yohei Morita;Hong Jiang.
Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors
Daniela Zychlinski;Axel Schambach;Ute Modlich;Tobias Maetzig.
Molecular Therapy (2008)
Long noncoding RNA Chast promotes cardiac remodeling.
Janika Viereck;Regalla Kumarswamy;Ariana Foinquinos;Ke Xiao.
Science Translational Medicine (2016)
Gene therapy on the move
Kerstin B. Kaufmann;Hildegard Büning;Anne Galy;Axel Schambach;Axel Schambach.
Embo Molecular Medicine (2013)
The phenotype of human STK4 deficiency
Hengameh Abdollahpour;Giridharan Appaswamy;Daniel Kotlarz;Daniel Kotlarz;Jana Diestelhorst;Jana Diestelhorst.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: